Analytical sensitivity

Related Cancer(s)

Methodology

Tumor marker

0.20 IU/ml

Liver, testis, Ovary

CL

AFP

0.4 mg/L

Multiple myeloma, some leukemia, and lymphomas

CL

Beta-2 microglobulin

0.5 U/ml

Breast

CL

CA 15-3

0.30 U/ml

Pancreas, Stomach, Bile duct, Gallbladder, Colon

CL

CA 19-9

0.3 U/ml

Ovary

CL

CA-125

< 3.0 pg/ml

Medullary thyroid carcinoma (MTC) and C-cell hyperplasia,

Multiple endocrine  neoplasia (MEN) type ll syndrome

CL

Calcitonin

0.20 ng/ml

Pancreas, Ovary, Breast, lung, Colon, thyroid gland, et...

CL

CEA

< 0.1 mIU/ml

Testicular and trophoblastic disease, germ cell tumors

Chorio carcinoma

ECL

βhCG

0.09 ng/ml

prostate

CL

PSA

1.0 ng/ml

thyroid gland

CL

Thyroglobulin

< 15 pmol/l

Ovary

ECL

HE4

0.80 ng/ml

Hodgkin- or Non-Hodgkin lymphoma, acute or chronic leukemia, breast and bronchial carcinoma

CL

Ferritin

< 1 U/ml

Gastrointestinal

ELISA

CA-242

N

Bladder, Non-bladder urologic cancer (ureters, renal pelvis, etc.)

Chromatography

NMP22